Market Analysis
Product Positioning
Competitor Monitoring
Find Global Buyers
Find Contact Information
Company Comparison
Supply Chain Optimization
Email Marketing
Customer Management
Blog
FAQs
About Topease
Agency Program
UzbekistanMEROS PHARM is one of the largest private wholesale pharmaceutical distribution companies in Uzbekistan, headquartered in Samarkand. It is the main operating and revenue-generating company within the Meros Group, a vertically integrated pharmaceutical group covering production, wholesale distribution, and retail. The company offers a full spectrum of distribution services, managing over 4,000 pharmaceutical product items and holding exclusive distribution rights for hundreds of medicines. It operates GDP-standard warehouse facilities across roughly 21,000 square meters and employs around 700 staff, serving thousands of regular customers nationwide. In 2025 it secured financing from the European Bank for Reconstruction and Development (EBRD) to support its operations and modernization.
| Import | Export |
|---|---|
|
Trade Records
6987
|
Trade Records
1
|
|
Suppliers
134
|
Buyers
1
|
|
Latest Import Date
2026-07
|
Latest Export Date
2025-12
|
According to Topease's global trade data, ООО 'MEROS PHARM' exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the ООО 'MEROS PHARM' distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, ООО 'MEROS PHARM' sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore ООО 'MEROS PHARM''s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| CHEMICAL WORKS OF GEDEON RICHTER PLC | ООО 'MEROS PHARM' | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| UAB "STADA-BALTICS" | ООО 'MEROS PHARM' | 2106 | 24 | $186,500 | 3,420 | Los Angeles |
| FARMAK UKRAINE | ООО 'MEROS PHARM' | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| BERLIN-CHEMIE AG | ООО 'MEROS PHARM' | 2106 | 24 | $186,500 | 3,420 | Los Angeles |
| SANDOZ PHARMACEUTICALS D D | ООО 'MEROS PHARM' | 3002 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into ООО 'MEROS PHARM''s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| КРКА Д Д НОВО МЕСТО | ООО 'MEROS PHARM' | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore ООО 'MEROS PHARM''s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access ООО 'MEROS PHARM''s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.